Collegium Pharmaceutical, Inc.
CEO
Vikram Karnani
IPO Date
2015-05-07
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Country
US
| 8,700 |
| $16.49 |
| 20 May 2026 | Freund John Gordon | director | S-Sale | Disposed | 20 | $34.05 |
| 18 May 2026 | Lurker Nancy | director | A-Award | Acquired | 8,741 | $0.00 |
| 18 May 2026 | Paya Carlos V | director | A-Award | Acquired | 8,741 | $0.00 |
| 18 May 2026 | Freund John Gordon | director | A-Award | Acquired | 8,741 | $0.00 |
| 18 May 2026 | Freund John Gordon | director | M-Exempt | Acquired | 8,700 | $16.49 |
| 18 May 2026 | Freund John Gordon | director | S-Sale | Disposed | 4,127 | $34.54 |
| 18 May 2026 | Freund John Gordon | director | M-Exempt | Disposed | 8,700 | $16.49 |
| 18 May 2026 | Glancy Donovan Michael | director | A-Award | Acquired | 17,482 | $0.00 |